Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases

BACKGROUND: Despite the emergence of diagnostic and clinical utility evidence in nephrology, publicly funded access to genomic testing is restricted in most health care systems. To establish genomic sequencing as a clinical test, an evaluation of cost-effectiveness is urgently required. METHODS: An...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayasinghe, Kushani, Wu, You, Stark, Zornitza, Kerr, Peter G., Mallett, Andrew J., Gaff, Clara, Martyn, Melissa, Goranitis, Ilias, Quinlan, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589690/
https://www.ncbi.nlm.nih.gov/pubmed/34805637
http://dx.doi.org/10.1016/j.ekir.2021.08.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589690/
https://www.ncbi.nlm.nih.gov/pubmed/34805637
http://dx.doi.org/10.1016/j.ekir.2021.08.028

Ejemplares similares